Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.39 AUD | +2.87% | +3.99% | -3.81% |
18/06 | Clinuvel Pharmaceuticals' Afamelanotide Found Effective in Fair-Skinned Parkinson’s Patients | MT |
18/06 | CLINUVEL Announces A Novel Clinical Program | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.81% | 511M | |
+2.22% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+76.30% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- CUV Stock
- News Clinuvel Pharmaceuticals Limited
- Clinuvel Pharmaceuticals Secures Patents for Melanocortins for Treatment of Central Nervous System Disorders